Jump to content
  • Dossier Advanced therapy medicinal products

    Novel gene and cell therapies are associated with high expectations in the treatment of incurable and hereditary diseases. Among them, CAR-T cell therapies have emerged as a major hope in cancer treatment.
    © BIOPRO Baden-Württemberg GmbH

  • Contact Stay in touch

    Would you like continue receiving e-mail notifications about our activities, up-to-date information, events, opportunities for cooperation and general industry information? Register here to stay informed about current issues.
    © denisismagilov / Adobe Stock

  • Industry report The healthcare industry in Baden-Württemberg

    BIOPRO's new report entitled "Healthcare Industry 2020: Facts and Figures for Baden-Württemberg" illustrates key figures like num the number of companies, number of employees and taxable turnover for the biotechnology, medical technology and pharmaceutical industry.
    © MR.LIGHTMAN / Adobe Stock

Call for Expression of Interest until 31st of July, 2025

PRECISEU is an EU project aimed at accelerating the development of personalized healthcare, particularly in the field of novel therapies. Within this framework, four Joint Interregional Projects will officially launch in 2026 and run for three years. These projects offer opportunities for mentoring and individual support, matchmaking for the formation of project consortia, Europe-wide collaboration, as well as preparation for the PRECISEU funding call. Currently, the call for Expressions of Interest (EoI) is open — a non-binding invitation for interested parties to participate with their project ideas and products in order to contribute to the Joint International Projects. The application deadline is July 31st, 2025.


Latest news

  • Press release - 09/07/2025

    Cancer can take decades for cancer-promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research Center have now developed a method that allows for the first time to reconstruct the temporal development—the evolution—of cancerous cells from a single tissue sample.

  • Press release - 08/07/2025

    Investing in a healthier future: The HORNBACH Group is supporting the new National Cancer Prevention Center in Heidelberg with a donation of five million euros. In the future, a new laboratory will conduct research into more effective early detection and screening methods.

  • Press release - 04/07/2025

    Scientists have been working on the artificial production of blood for several decades. Making a new discovery, researchers from the Institute for Cellular Biology and Immunology Thurgau at the University of Konstanz, in collaboration with Queen Mary University of London, have come an important step closer to this goal.

  • Press release - 02/07/2025

    The European Commission has launched a new strategy to make Europe the most attractive place in the world for life sciences by 2030. Life sciences – the study of living systems, from cells to ecosystems – are central to our health, environment and economy. They drive innovation in medicine, food and sustainable production, adding nearly €1.5 trillion in value to the EU economy and supporting 29 million jobs across the Union.

  • Computer tool opens up new ways to address antibiotic resistance - 02/07/2025

    Bacteriophages - viruses that specifically attack and destroy bacteria - are emerging as promising alternatives to antibiotics in the fight against drug-resistant infections. To speed this effort, researchers have created PhARIS, a computational tool that mines genomic data to pinpoint phages that are effective against S. aureus. By rapidly matching phage and pathogen, PhARIS can accelerate the development of targeted phage therapies.

Website address: https://www.gesundheitsindustrie-bw.de/en